skin pore.
Conditions
Interventions
Intervention 1: Intervention group: 17 patients are treated with 1550nm non-ablative fractional laser 4 times with spot size 12mm in Fitzpatrick 1 and 2, 30% overlap and in Fitzpatrick 4 and 5, 25% ov
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: People aged 18 to 50 with skin pores Signing a voluntary agreement Female gender
Exclusion criteria
Exclusion criteria: Age over 50 and under 18 years Pregnancy Having acne scars Tendency to create scars or keloids Smoking Filler injection in the last 6 months Uncontrolled systemic disease Photosensitivity Consumption of AHA or BHA in the last 1 month Topical tretinoid in the last 1 month Anti-hormonal drugs (anti-androgens) such as spironolactone and cyproterone acetate up to the last 6 months History of ablative lasers and non-ablative facial rejuvenation in the last 1 yea breastfeeding systemic isotretinoin up to the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin pore score obtained from Visioface device. Timepoint: Pore ??scoring with the Visioface device in the laser group is done before the first session, two months later, four months later, and six months later. . Mesobotox is examined before injection, two months later, four months later, and six months later. Method of measurement: Scoring the number of skin pores with Visioface device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactneda serkani
Tehran University of Medical Sciences
Outcome results
None listed